Ryan M Greene

Title: Innovations of Ryan M Greene

Introduction

Ryan M Greene is an accomplished inventor based in San Antonio, TX (US). He has made significant contributions to the field of biomedical research, particularly in the detection and diagnosis of infections. With a total of 2 patents, Greene's work has the potential to impact both human and animal health.

Latest Patents

Greene's latest patents focus on compositions and methods for the detection and diagnosis of infections. The patents describe nucleotide and amino acid sequences of antigenic polypeptides, specifically gp50, gp50a, gp50b, and gp50c. These compositions contain synthetic antigenic polypeptides of larval origin, which are prepared using the sequences provided. The patents also detail probes and primers for the detection or amplification of nucleic acid molecules. The polypeptides can be administered to humans or animals to protect against infections. Additionally, they serve as research tools for studying and as reagents in assays for the detection of antibodies in biological samples. The methods outlined in these patents are sensitive and specific, utilizing stable recombinant or synthetic antigenic polypeptides or nucleic acid molecules encoding the larval polypeptides.

Career Highlights

Ryan M Greene works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization allows him to contribute to public health initiatives and advancements in medical research.

Collaborations

Some of Greene's notable coworkers include Patricia P Wilkins and Victor C W Tsang. Their collaboration enhances the research efforts and innovation within their field.

Conclusion

Ryan M Greene's contributions to the field of infection detection and diagnosis exemplify the importance of innovation in biomedical research. His patents reflect a commitment to improving health outcomes for both humans and animals.